News
HSA Adverse Drug Reaction News 2018 May, Vol.20 No.1
Professionals
Allied Health Professionals
Dental Practitioners
Doctors
Pharmacists
TCM Practitioners
8 May 2018
Access and read HSA's May 2018 bulletin which covers adverse events for health products and other news.
HSA Adverse Drug Reaction News 2018 May, Vol.20 No.1
The aim of the news bulletin is to increase the awareness of adverse events related to health products amongst healthcare professionals, and to promote adverse event reporting related to health products.
This issue includes the following topics:
Gadolinium-based contrast agents and risk of gadolinium brain deposits
AE Case in Focus: Test Yourself
Risk of severe cutaneous adverse reactions with recombinant human erythropoeitins
Update on canagliflozin and risk of lower limb amputation
Caution on the use of lysozyme-containing products in patients with known egg allergy
Answers to AE Case in Focus: Test Yourself
List of Dear Healthcare Professional Letters (1 Dec 2017 – 30 Apr 2018)
Non-steroidal anti-inflammatory drugs and cardiovascular risk – An update and reminder